Location · Illinois
Clinical trials recruiting in Illinois
890 recruiting studies have at least one site in Illinois; 285 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Illinois.
890 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
JenaValve Technology, Inc.
- Location
- Chicago, IL + 33 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 3
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Novo Nordisk A/S
- Location
- Chicago, IL + 42 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
Transcend Therapeutics
- Location
- Chicago, IL + 36 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
Amgen
- Location
- Peoria, IL + 2 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingPhase 3
A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT)
Vaderis Therapeutics AG
- Location
- Chicago, IL + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
ARS Pharmaceuticals, Inc.
- Location
- Glenview, IL + 1 other US site
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Amgen
- Location
- Hazel Crest, IL + 117 other US sites
- Eligibility basics
- Ages 18–99
- Recruiting
Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes
Providence Medical Technology, Inc.
- Location
- Hinsdale, IL + 9 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old
Neurocrine Switzerland GmbH
- Location
- Chicago, IL + 10 other US sites
- Eligibility basics
- Ages 4 mo–3
- RecruitingPhase 3
Brexanolone Lifting Outcomes Of Moms
Lipocine Inc.
- Location
- Chicago, IL + 15 other US sites
- Eligibility basics
- Ages 15–45 · Women only
- Recruiting
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Medtronic Cardiovascular
- Location
- Chicago, IL + 68 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Corxel Pharmaceuticals
- Location
- Chicago, IL + 32 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Edwards Lifesciences
- Location
- Chicago, IL + 44 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
DiaMedica Therapeutics Inc
- Location
- Peoria, IL + 35 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
AbbVie
- Location
- Chicago, IL + 87 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Incyte Corporation
- Location
- Chicago, IL + 65 other US sites
- Eligibility basics
- Ages 2–11
- RecruitingPhase 3
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
Basilea Pharmaceutica
- Location
- Chicago, IL + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bristol-Myers Squibb
- Location
- Chicago, IL + 39 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
Sarepta Therapeutics, Inc.
- Location
- Chicago, IL + 10 other US sites
- Eligibility basics
- Ages 2+ · Men only
- Recruiting
Cephea Early Feasibility Study
Abbott Medical Devices
- Location
- Chicago, IL + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
COUR Pharmaceutical Development Company, Inc.
- Location
- Chicago, IL + 44 other US sites
- Eligibility basics
- Ages 12–35
- RecruitingPhase 2
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Novo Nordisk A/S
- Location
- Chicago, IL + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Vertex Pharmaceuticals Incorporated
- Location
- O'Fallon, IL + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Novo Nordisk A/S
- Location
- Chicago, IL + 14 other US sites
- Eligibility basics
- Ages 18+